217 related articles for article (PubMed ID: 32028139)
1. Treatment strategies and subsequent changes in the patient-reported quality-of-life among elderly patients with atrial fibrillation.
Miura K; Ikemura N; Kimura T; Katsumata Y; Ueda I; Tanimoto K; Ohki T; Shinmura D; Negishi K; Fukuda K; Takatsuki S; Kohsaka S
Am Heart J; 2020 Apr; 222():83-92. PubMed ID: 32028139
[TBL] [Abstract][Full Text] [Related]
2. Cohort profile: patient characteristics and quality-of-life measurements for newly-referred patients with atrial fibrillation-Keio interhospital Cardiovascular Studies-atrial fibrillation (KiCS-AF).
Ikemura N; Spertus JA; Kimura T; Mahaffey K; Piccini JP; Inohara T; Ueda I; Tanimoto K; Suzuki M; Nakamura I; Akaishi M; Mitamura H; Fukuda K; Takatsuki S; Kohsaka S
BMJ Open; 2019 Dec; 9(12):e032746. PubMed ID: 31857312
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Sex Differences in the Initial Symptom Burden, Applied Treatment Strategy, and Quality of Life in Japanese Patients With Atrial Fibrillation.
Ikemura N; Kohsaka S; Kimura T; Ueda I; Katsumata Y; Nishiyama T; Aizawa Y; Tanimoto K; Momiyama Y; Akaishi M; Mitamura H; Fukuda K; Spertus JA; Takatsuki S
JAMA Netw Open; 2019 Mar; 2(3):e191145. PubMed ID: 30924896
[TBL] [Abstract][Full Text] [Related]
4. Rate versus rhythm control in patients with newly diagnosed atrial fibrillation: Effects of the treatment timing on health status outcomes.
Nakamaru R; Ikemura N; Spertus JA; Kimura T; Katsumata Y; Fujisawa T; Ueno K; Inoue S; Ueda I; Fukuda K; Takatsuki S; Kohsaka S
Am Heart J; 2022 Dec; 254():156-165. PubMed ID: 36099976
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life in patients with atrial fibrillation treated with rhythm control versus rate control: insights from a prospective international registry (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation: RECORD-AF).
Ha AC; Breithardt G; Camm AJ; Crijns HJ; Fitzmaurice GM; Kowey PR; Le Heuzey JY; Naditch-Brûlé L; Prystowsky EN; Schwartz PJ; Torp-Pedersen C; Weintraub WS; Dorian P
Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):896-904. PubMed ID: 25387780
[TBL] [Abstract][Full Text] [Related]
6. Defining Clinically Important Difference in the Atrial Fibrillation Effect on Quality-of-Life Score.
Holmes DN; Piccini JP; Allen LA; Fonarow GC; Gersh BJ; Kowey PR; O'Brien EC; Reiffel JA; Naccarelli GV; Ezekowitz MD; Chan PS; Singer DE; Spertus JA; Peterson ED; Thomas L
Circ Cardiovasc Qual Outcomes; 2019 May; 12(5):e005358. PubMed ID: 31092022
[TBL] [Abstract][Full Text] [Related]
7. Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.
Mark DB; Anstrom KJ; Sheng S; Piccini JP; Baloch KN; Monahan KH; Daniels MR; Bahnson TD; Poole JE; Rosenberg Y; Lee KL; Packer DL;
JAMA; 2019 Apr; 321(13):1275-1285. PubMed ID: 30874716
[TBL] [Abstract][Full Text] [Related]
8. Symptom burden and treatment perception in patients with atrial fibrillation, with and without a family history of atrial fibrillation.
Fujisawa T; Kimura T; Kohsaka S; Ikemura N; Katsumata Y; Miyama H; Nakajima K; Nishiyama T; Aizawa Y; Kanki H; Nagami K; Fukuda K; Takatsuki S
Heart Vessels; 2021 Feb; 36(2):267-276. PubMed ID: 32902701
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Outcomes and Improvements in Quality of Life in Patients with Atrial Fibrillation Treated with Catheter Ablation vs. Antiarrhythmic Drugs.
Zheng ZH; Fan J; Ji CC; Cheng YJ; Chen XM; Jiang JZ; Wu SH
Am J Cardiovasc Drugs; 2021 May; 21(3):299-320. PubMed ID: 33000397
[TBL] [Abstract][Full Text] [Related]
10. Catheter ablation vs. antiarrhythmic drugs as 'first-line' initial therapy for atrial fibrillation: a pooled analysis of randomized data.
Chen S; Pürerfellner H; Ouyang F; Kiuchi MG; Meyer C; Martinek M; Futyma P; Zhu L; Schratter A; Wang J; Acou WJ; Ling Z; Yin Y; Liu S; Sommer P; Schmidt B; Chun JKR
Europace; 2021 Dec; 23(12):1950-1960. PubMed ID: 34405878
[TBL] [Abstract][Full Text] [Related]
11. Baseline and Postprocedural Health Status Outcomes in Contemporary Patients With Atrial Fibrillation Who Underwent Catheter Ablation: A Report from the Japanese Outpatient Registry.
Ikemura N; Spertus JA; Kimura T; Katsumata Y; Fujisawa T; Ueda I; Fukuda K; Takatsuki S; Kohsaka S
J Am Heart Assoc; 2021 Sep; 10(18):e019983. PubMed ID: 34514817
[TBL] [Abstract][Full Text] [Related]
12. Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study.
Hagens VE; Ranchor AV; Van Sonderen E; Bosker HA; Kamp O; Tijssen JG; Kingma JH; Crijns HJ; Van Gelder IC;
J Am Coll Cardiol; 2004 Jan; 43(2):241-7. PubMed ID: 14736444
[TBL] [Abstract][Full Text] [Related]
13. Effect of Compliance to Updated AHA/ACC Performance and Quality Measures Among Patients With Atrial Fibrillation on Outcome (from Japanese Multicenter Registry).
Inohara T; Kimura T; Ueda I; Ikemura N; Tanimoto K; Nishiyama N; Aizawa Y; Nishiyama T; Katsumata Y; Fukuda K; Takatsuki S; Kohsaka S
Am J Cardiol; 2017 Aug; 120(4):595-600. PubMed ID: 28651850
[TBL] [Abstract][Full Text] [Related]
14. Improvements in symptoms and quality of life in patients with paroxysmal atrial fibrillation treated with radiofrequency catheter ablation versus antiarrhythmic drugs.
Reynolds MR; Walczak J; White SA; Cohen DJ; Wilber DJ
Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):615-23. PubMed ID: 20940250
[TBL] [Abstract][Full Text] [Related]
15. Optimal rhythm-control strategy for recurrent atrial tachycardia after catheter ablation of persistent atrial fibrillation: a randomized clinical trial.
Zhang XD; Gu J; Jiang WF; Zhao L; Zhou L; Wang YL; Liu YG; Liu X
Eur Heart J; 2014 May; 35(20):1327-34. PubMed ID: 24497338
[TBL] [Abstract][Full Text] [Related]
16. Clinical Outcomes of Rhythm Control Strategies for Asymptomatic Atrial Fibrillation According to the Quality-of-Life Score: The CODE-AF (Comparison Study of Drugs for Symptom Control and Complication Prevention of Atrial Fibrillation) Registry.
Kim JY; Park HS; Park HW; Choi EK; Park JK; Kim JB; Kang KW; Shim J; Joung B; Park KM
J Am Heart Assoc; 2022 Sep; 11(18):e025956. PubMed ID: 36073646
[TBL] [Abstract][Full Text] [Related]
17. Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
Jenkins LS; Brodsky M; Schron E; Chung M; Rocco T; Lader E; Constantine M; Sheppard R; Holmes D; Mateski D; Floden L; Prasun M; Greene HL; Shemanski L
Am Heart J; 2005 Jan; 149(1):112-20. PubMed ID: 15660042
[TBL] [Abstract][Full Text] [Related]
18. Symptom Under-Recognition of Atrial Fibrillation Patients in Consideration for Catheter Ablation: A Report From the KiCS-AF Registry.
Katsumata Y; Kohsaka S; Ikemura N; Ueda I; Hashimoto K; Yamashita T; Miyama H; Fujisawa T; Kimura T; Tanimoto K; Momiyama Y; Suzuki M; Fukuda K; Takatsuki S
JACC Clin Electrophysiol; 2021 May; 7(5):565-574. PubMed ID: 33358669
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the real world effectiveness of catheter ablation and drug therapy in atrial fibrillation patients in a Chinese setting.
Du X; Guo L; He X; Jia Y; Wu J; Long D; Yu R; Sang C; Liu X; Yin H; Xuan J; Dong J; Ma C
BMC Cardiovasc Disord; 2017 Jul; 17(1):204. PubMed ID: 28750608
[TBL] [Abstract][Full Text] [Related]
20. Cardioversion and subsequent quality of life and natural history of atrial fibrillation.
Pokorney SD; Kim S; Thomas L; Fonarow GC; Kowey PR; Gersh BJ; Mahaffey KW; Peterson ED; Piccini JP;
Am Heart J; 2017 Mar; 185():59-66. PubMed ID: 28267476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
